News
Press Release: Adams and Underwood Secure Over $363 Million for Maternal Health in FY25 Appropriations Package | Stock News
6+ hour, 9+ min ago (411+ words) The Black Maternal Health Caucus secured $363 million for maternal health priorities, including $72 million in Momnibus funding. BMHC Secures Funding for Maternal Health Initiatives: The Black Maternal Health Caucus has successfully secured over $363 million for maternal health priorities in the Full-Year…...
Press Release: Mc Clellan and Strickland Lead Congressional Effort for Improved Maternal Health Care for Servicemembers | Stock News
3+ week, 3+ day ago (311+ words) Congresswomen address maternal health care concerns: Congresswoman Jennifer Mc Clellan and Congresswoman Marilyn Strickland, alongside 14 House members, sent a letter to Defense Secretary Pete Hegseth urging immediate action to improve maternal health care for military servicemembers within the Military Health…...
New Bill: Senator Richard Blumenthal introduces S. 4149: Social Determinants for Moms Act | Stock News
1+ mon, 2+ week ago (346+ words) We have received text from S. 4149: Social Determinants for Moms Act. This bill was received on 2026-03-19, and currently has 2 cosponsors. The Secretary of Health and Human Services is required to convene a task force that includes representatives from various government departments,…...
Press Release: Underwood, Adams, and Booker Reintroduce Comprehensive Legislation to Address Maternal Health Crisis in the U. S. | Stock News
1+ mon, 4+ week ago (395+ words) Representatives Underwood, Adams, and Senator Booker reintroduce the Momnibus, a legislative package to address maternal health crises. Legislators reintroduce the Momnibus: Representatives Lauren Underwood and Alma Adams, alongside Senator Cory Booker, have reintroduced the Momnibus, comprising 14 bills aimed at addressing…...
Greenwich Life Sciences, Inc. Announces Presentation of FLAMINGO-01 Phase III Clinical Trial Data at AACR Meeting 2026 | GLSI Stock News
1+ mon, 4+ week ago (454+ words) Greenwich Life Sciences announced presentations at AACR 2026 for its Phase III trial evaluating GLSI-100 immunotherapy in breast cancer patients. FLAMINGO-01 is a Phase III clinical trial assessing the efficacy of GLSI-100 immunotherapy in preventing breast cancer recurrences. The AACR Meeting…...